Global Noninvasive Cancer Diagnostics Market: Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

16/mag/2018 14:59:55 PBIGP Contatta l'autore

 

 

Global Noninvasive Cancer Diagnostics Market: By Product (Tests Kits & Reagents and Consumables) By Application (Lung Cancer, Breast Cancer, Solid tumors, Blood cancer, Others), By Technique (Immunochemistry/Immunoassay, Molecular Diagnostics, Clinical Chemistry, and Others), Distribution Channel (Hospitals, Diagnostic Center, Oncology Centers and Others) and Geography - Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2013-2017 and Forecast 2018-2024

 

Global noninvasive cancer diagnostics market was valued at US $ XX Mn in 2017 and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024

 

Market Outline: Noninvasive Cancer Diagnostics Market

The noninvasive technique is a procedure that does not require insertion of an instrument through the skin. With the advancements in the technology, there are various treatment procedures that are being used. The advent of the modern diagnostic techniques helps in the detection of cancer. The noninvasive techniques play a vital role in the diagnosis of cancer replacing the invasive tests.

 

Market Dynamics: Noninvasive Cancer Diagnostics Market

Increase in the prevalence of chronic diseases such as cancer is the key factor attributed for the growth of the noninvasive cancer diagnostics market. The technological advancements play a vital role in the development of the noninvasive techniques. Rising demand for the noninvasive and minimally invasive diagnosis is adding fuel for the growth of the market. The growing geriatric population along with growing health issues and rising awareness among the patient population regarding various treatment options is boosting the growth of the noninvasive cancer diagnostics market. The initiation taken by the government and non-profitable organizations to create awareness regarding the early diagnosis of the disease is anticipated to drive the growth of the noninvasive cancer diagnostics market.

 

Free sample of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/noninvasive-cancer-diagnostics-market/#ulp-4H8Z4LpNMLEuOnnx

 

Market Scope: Noninvasive Cancer Diagnostics Market

Noninvasive cancer diagnostics market is segmented based on the product type, application, and technique

Based on the product, the market is segmented into the following:

·         Test Kits & Reagents

·         Consumables

Based on the application, the market is segmented into the following:

·         Lung Cancer

·         Breast Cancer

·         Solid tumors

·         Blood cancer

·         Others

Based on the technique, the market is segmented into the following:

·         Immunochemistry/Immunoassay

·         Molecular Diagnostics

·         Clinical Chemistry

·         Others

Based on distribution channel, the market is segmented into:

·         Hospitals

·         Diagnostic Centers

·         Oncology Centers

·         Others

 

Free TOC of this report is available upon request @

https://www.precisionbusinessinsights.com/market-reports/noninvasive-cancer-diagnostics-market/#ulp-c654SbFYO64MsOhu

 

Regional Analysis:  Noninvasive Cancer Diagnostics Market

Geographically, global noninvasive cancer diagnostics market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America noninvasive cancer diagnostics market is the dominating market when compared with that of the other regional markets. Owing to its technological advancements and the deep-rooted healthcare infrastructure, the noninvasive cancer diagnostics market is growing significantly in this region. The increase in the awareness among the people regarding the modern treatment methods is boosting the growth of the market in this region. According to American Cancer Society, there were more than 1,660,290 new cases diagnosed in 2013. The well-structured reimbursement policies are enhancing the growth of the market in this region.

 

Need more information about this report @

https://www.precisionbusinessinsights.com/market-reports/noninvasive-cancer-diagnostics-market/#ulp-14mlyhjMGhVjZqa3

 

Competition Assessment: Noninvasive Cancer Diagnostics Market

Some of the players in the global noninvasive cancer diagnostics market include:

·         Digene Corporation (U.S.)

·         Gen-Probe Incorporated (U.S.)

·         IVDiagnostics, Inc. (U.S.)

·         A&G Pharmaceutical, Inc. (U.S.)

·         Affymetrix Inc. (U.S.)

·         AVIVA Biosciences Corporation (U.S.)

·         BIOVIEW Inc. (U.S.)

·         Laboratory Corporation of America Holdings (LabCorp) (U.S.)

·         Quest Diagnostics Incorporated Cancer Genetics Inc. (U.S.)

 

Notable Market Developments: Noninvasive Cancer Diagnostics Market

Ø  In May 2018, FDA has approved first Non-Invasive DNA screening test for colorectal cancer

 

 

Get access to full summary @

https://www.precisionbusinessinsights.com/market-reports/noninvasive-cancer-diagnostics-market/

 

About Precision Business Insights

Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.

Contact to Precision Business Insights,

Kemp House,

152 – 160 City Road,

London EC1V 2NX

Email: sales@precisionbusinessinsights.com

Toll Free (US):+1-866-598-1553

Website @https://www.precisionbusinessinsights.com

 

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl